Allergan, Teva Settle Opioid Trial As Closing Arguments Begin in San Francisco
The two drug companies have agreed to pay $54 million to settle San Francisco’s opioid trial on Tuesday, but closing arguments continue against a third defendant, Walgreens.
CEO of Speaker Media and Marketing, is the "Secret Weapon of Personal Injury Lawyers and Trial Attorneys" throughout the United States. Specializing as a marketing consultant to lawyers, with a primary focus on content marketing, social media, online video and mobile marketing strategies.
Click Here To Read The Full Article